Peripheral artery disease

### What you need to know Peripheral artery disease affects around 13% of the Western population who are more than 50 years old.1 It is most commonly due to atherosclerosis, where an atherosclerotic plaque causes arterial stenosis or occlusion. This results in a reduction in blood flow to the affected limb. Most patients are asymptomatic, but many experience intermittent claudication (pain on walking). Critical limb ischaemia occurs when the reduction in blood flow is so severe that it causes pain on rest or tissue loss (ulceration or gangrene).1 Atherosclerosis is a systemic disease. Some 60% of patients with peripheral artery disease will have ischaemic heart disease, and 30% have cerebrovascular disease.2 Within five years of diagnosis, 10-15% of patients with intermittent claudication will die from cardiovascular disease.3 Therefore, management begins with identification and modification of risk factors that are common to peripheral artery disease, heart disease, and stroke. ### Sources and selection criteria We used Healthcare Databases Advanced Search (HDAS) to search Embase, Medline, and PubMed for the most up to date systematic reviews and meta-analyses or alternative highest level of evidence on peripheral artery disease or intermittent claudication. Searches were performed during September 2017 with no date limits applied. We also consulted national and international guidelines, particularly those published by the National Institute for Health and Care Excellence (NICE) and the Trans-Atlantic Inter-Society Consensus for the Management of Peripheral Artery Disease …

[1]  A. Sharrett,et al.  HbA 1 c and Peripheral Arterial Disease in Diabetes The Atherosclerosis Risk in Communities study , 2006 .

[2]  J. W. Stevens,et al.  Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication , 2012, The British journal of surgery.

[3]  L. Fleisher,et al.  2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2017, Journal of the American College of Cardiology.

[4]  K. Eriksson,et al.  Outcome of ischemic foot ulcer in diabetic patients who had no invasive vascular intervention. , 2013, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[5]  M. Lepäntalo,et al.  Outcome of unreconstructed chronic critical leg ischaemia. , 1996, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[6]  S. Kuys,et al.  The Queensland high risk foot form (QHRFF) – is it a reliable and valid clinical research tool for foot disease? , 2014, Journal of Foot and Ankle Research.

[7]  W. O'Fallon,et al.  Peripheral arterial disease, diabetes, and mortality. , 2004, Diabetes care.

[8]  Alonso Carrasco-Labra,et al.  GRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT. , 2017, Journal of clinical epidemiology.

[9]  J. Dormandy Management of the diabetic foot. , 1979, Annals of the Royal College of Surgeons of England.

[10]  R. Holman,et al.  UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes. , 2002, Diabetes care.

[11]  D G Smith,et al.  Diagnostic utility of the history and physical examination for peripheral vascular disease among patients with diabetes mellitus. , 1997, Journal of clinical epidemiology.

[12]  Kenneth W Lin,et al.  Nicotine receptor partial agonists for smoking cessation. , 2011, American family physician.

[13]  Peter Libby,et al.  Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. , 2002, JAMA.

[14]  A. Panju,et al.  Does the clinical examination predict lower extremity peripheral arterial disease? , 2006, JAMA.

[15]  L. Uccioli,et al.  High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study , 2006, Diabetologia.

[16]  G. Guyatt,et al.  Antithrombotic therapy in peripheral artery disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[17]  R. Hamman,et al.  Effect of diagnostic criteria on the prevalence of peripheral arterial disease. The San Luis Valley Diabetes Study. , 1995, Circulation.

[18]  J. Bosch,et al.  Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial. , 2018, Lancet.

[19]  L. Norgren,et al.  An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II) , 2015, Vascular medicine.

[20]  G. Antoniou,et al.  Statin therapy in lower limb peripheral arterial disease: Systematic review and meta-analysis. , 2014, Vascular pharmacology.

[21]  D. Dawson,et al.  Smoking cessation is associated with decreased mortality and improved amputation-free survival among patients with symptomatic peripheral artery disease. , 2014, Journal of vascular surgery.

[22]  I. Chetter,et al.  Do angiotensin converting enzyme inhibitors improve walking distance in patients with symptomatic lower limb arterial disease? A systematic review and meta-analysis of randomised controlled trials. , 2011, International journal of surgery.

[23]  Manesh R. Patel,et al.  Rivaroxaban in Peripheral Artery Disease after Revascularization. , 2020, The New England journal of medicine.

[24]  Duane R Hennion,et al.  Diagnosis and treatment of peripheral arterial disease. , 2013, American family physician.

[25]  Andrew Phillips,et al.  Health status differentials across rural and remote Australia. , 2009, The Australian journal of rural health.

[26]  A. T. Cariski,et al.  Cilostazol in intermittent claudication. , 2002, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[27]  W. Marston,et al.  Diabetic Foot Ulcers and Vascular Insufficiency: Our Population Has Changed, but Our Methods Have Not , 2011, Journal of diabetes science and technology.

[28]  Philip Greenland,et al.  Peripheral artery disease, diabetes, and reduced lower extremity functioning. , 2002, Diabetes care.

[29]  David G Armstrong,et al.  The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI). , 2014, Journal of vascular surgery.

[30]  R. Fried Diagnosis and treatment of peripheral arterial disease. , 2002, JAMA.

[31]  M. Prins,et al.  Influence of smoking on incidence and prevalence of peripheral arterial disease. , 2004, Journal of vascular surgery.

[32]  M. Koelemay,et al.  Systematic review of exercise training or percutaneous transluminal angioplasty for intermittent claudication , 2012, The British journal of surgery.

[33]  D. Armstrong,et al.  Guidelines on offloading foot ulcers in persons with diabetes (IWGDF 2019 update) , 2020, Diabetes/metabolism research and reviews.

[34]  A. Vinik,et al.  Methods for evaluation of peripheral neurovascular dysfunction. , 2001, Diabetes technology & therapeutics.

[35]  P. Lazzarini,et al.  Pathway to ending avoidable diabetes‐related amputations in Australia , 2018, The Medical journal of Australia.

[36]  Mark A. Creager,et al.  Cholesterol Reduction With Atorvastatin Improves Walking Distance in Patients With Peripheral Arterial Disease , 2003, Circulation.

[37]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[38]  J. Dimick,et al.  Explaining racial disparities in mortality after abdominal aortic aneurysm repair. , 2009, Journal of vascular surgery.

[39]  M. Venermo,et al.  Analysis of the Elective Treatment Process for Critical Limb Ischaemia with Tissue Loss: Diabetic Patients Require Rapid Revascularisation. , 2017, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[40]  J. Reekers,et al.  Performance of prognostic markers in the prediction of wound healing or amputation among patients with foot ulcers in diabetes: a systematic review , 2016, Diabetes/metabolism research and reviews.

[41]  D. Armstrong,et al.  Effectiveness of offloading interventions to heal foot ulcers in persons with diabetes: a systematic review , 2020, Diabetes/metabolism research and reviews.

[42]  J. Woods,et al.  The Roles of ACE Inhibitors in Lower Extremity Peripheral Artery Disease , 2016, American journal of therapeutics.

[43]  A. Gardner,et al.  Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis. , 1995, JAMA.

[44]  R. Price,et al.  High burden of diabetic foot infections in the top end of Australia: An emerging health crisis (DEFINE study). , 2015, Diabetes research and clinical practice.

[45]  G. Gill,et al.  Amputation and mortality in new-onset diabetic foot ulcers stratified by etiology. , 2003, Diabetes care.

[46]  R. Lassila,et al.  Cigarette smoking and the outcome after lower limb arterial surgery. , 1988, Acta chirurgica Scandinavica.

[47]  Sicco A Bus,et al.  Diabetic Foot Ulcers and Their Recurrence. , 2017, The New England journal of medicine.

[48]  F. Chappell,et al.  Ankle brachial index for the diagnosis of lower limb peripheral arterial disease. , 2016, The Cochrane database of systematic reviews.

[49]  Sheyu Li,et al.  Intensive walking exercise for lower extremity peripheral arterial disease: A systematic review and meta‐analysis , 2016, Journal of diabetes.

[50]  M. Koelemay,et al.  Systematic review of exercise training or percutaneous transluminal angioplasty for intermittent claudication , 2012, The British journal of surgery.

[51]  B. Koes,et al.  Effectiveness of interventions for secondary Raynaud's phenomenon: a systematic review. , 2011, Archives of physical medicine and rehabilitation.

[52]  J. Berger Antithrombotic therapy in peripheral artery disease , 2017, The Lancet.

[53]  Uk-Prospective-Diabetes-Study-Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) , 1998, The Lancet.

[54]  Emilia J. Flores,et al.  Using a 10-step framework to support the implementation of an evidence-based clinical pathways programme , 2018, BMJ Quality & Safety.

[55]  C. Steffen,et al.  Diabetic major amputation in Far North Queensland 1998-2008: what is the Gap for Indigenous patients? , 2013, The Australian journal of rural health.

[56]  J. Black,et al.  The Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification independently predicts wound healing in diabetic foot ulcers , 2017, Journal of vascular surgery.

[57]  Benjamin A Lipsky,et al.  Practical Guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update) , 2020, Diabetes/metabolism research and reviews.

[58]  D. Mikhailidis,et al.  Cilostazol for intermittent claudication. , 2014, The Cochrane database of systematic reviews.

[59]  C Ahn,et al.  Prevalence of coexistence of coronary artery disease, peripheral arterial disease, and atherothrombotic brain infarction in men and women > or = 62 years of age. , 1994, The American journal of cardiology.

[60]  G. Leng,et al.  Bypass surgery for chronic lower limb ischaemia. , 2008, The Cochrane database of systematic reviews.

[61]  M. Flather,et al.  Characteristics and treatments of patients with peripheral arterial disease referred to UK vascular clinics: results of a prospective registry. , 2007, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[62]  F. Fiordaliso,et al.  Prospective study on microangiopathy in type 2 diabetic foot ulcer , 2016, Diabetologia.

[63]  Internal Clinical Guidelines Team,et al.  Diabetic Foot Problems: Prevention and Management , 2015 .

[64]  C. Steffen,et al.  Surgical management of diabetic foot complications: the Far North Queensland profile. , 1998, The Australian and New Zealand journal of surgery.

[65]  A. House,et al.  The effect of cessation of smoking on the accumulative survival rates of patients with symptomatic peripheral vascular disease , 1983, The Medical journal of Australia.

[66]  D. Clement A randomised, blinded, trial of Clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) , 1996 .

[67]  Amy T. Wang,et al.  A systematic review for the screening for peripheral arterial disease in asymptomatic patients. , 2015, Journal of Vascular Surgery.

[68]  A. Sharrett,et al.  HbA1c and peripheral arterial disease in diabetes: the Atherosclerosis Risk in Communities study. , 2006, Diabetes care.

[69]  Mohammad Hassan Murad,et al.  The management of diabetic foot: A clinical practice guideline by the Society for Vascular Surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine. , 2016, Journal of vascular surgery.

[70]  A. Silman,et al.  Iloprost and cisaprost for Raynaud's phenomenon in progressive systemic sclerosis. , 1998, The Cochrane database of systematic reviews.

[71]  Neil R. Powe,et al.  Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus , 2004, Annals of Internal Medicine.

[72]  Elie A Akl,et al.  GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. , 2013, Journal of clinical epidemiology.

[73]  E. Peterson,et al.  High mortality risks after major lower extremity amputation in Medicare patients with peripheral artery disease. , 2013, American heart journal.

[74]  Deepak L. Bhatt,et al.  International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. , 2006, JAMA.

[75]  G Rayman,et al.  Blood flow in the skin of the foot related to posture in diabetes mellitus , 1986, British medical journal.

[76]  G. Engström,et al.  Amputation-free survival in patients with diabetic foot ulcer and peripheral arterial disease: Endovascular versus open surgery in a propensity score adjusted analysis. , 2020, Journal of diabetes and its complications.

[77]  Jillian T Henderson,et al.  Behavioral Counseling and Pharmacotherapy Interventions for Tobacco Cessation in Adults, Including Pregnant Women: A Review of Reviews for the U.S. Preventive Services Task Force , 2015, Annals of Internal Medicine.

[78]  L. Kraiss,et al.  Statin therapy after infrainguinal bypass surgery for critical limb ischemia is associated with improved 5-year survival. , 2012, Journal of vascular surgery.

[79]  H. Schünemann,et al.  [GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction.] , 2017, Recenti progressi in medicina.

[80]  B. Modarai,et al.  Comparative Efficacy and Safety of Different Antiplatelet Agents for Prevention of Major Cardiovascular Events and Leg Amputations in Patients with Peripheral Arterial Disease: A Systematic Review and Network Meta-Analysis , 2015, PloS one.

[81]  David Schultz,et al.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) , 1996, The Lancet.

[82]  L. Watson,et al.  Exercise for intermittent claudication. , 2017, The Cochrane database of systematic reviews.

[83]  E. Barrett-Connor,et al.  TABLE 1 Prevalence of PAD by traditional assessment : intermittent claudication and pulse palpation % Claudication % Pulse abnormalities Rose Femoral Posterior Dorsalis n Rose , 2005 .

[84]  L. Norgren,et al.  A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) Initiative. , 2017, Circulation.

[85]  P. Lazzarini,et al.  Australian diabetes-related foot disease strategy 2018-2022: The first step towards ending avoidable amputations within a generation , 2017 .

[86]  E. Boerwinkle,et al.  Ethnic differences in peripheral arterial disease in the NHLBI Genetic Epidemiology Network of Arteriopathy (GENOA) study , 2003, Vascular medicine.

[87]  J. Reekers,et al.  Effectiveness of bedside investigations to diagnose peripheral artery disease among people with diabetes mellitus: a systematic review , 2016, Diabetes/metabolism research and reviews.

[88]  W. Jeffcoate,et al.  Guidelines on the classification of diabetic foot ulcers (IWGDF 2019) , 2020, Diabetes/metabolism research and reviews.

[89]  M. M. Joosten,et al.  Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men. , 2012, JAMA.

[90]  Kirk D. Wyatt,et al.  Varenicline for smoking cessation: efficacy, safety, and treatment recommendations , 2010, Patient preference and adherence.

[91]  W. Aronow,et al.  Effect of simvastatin versus placebo on treadmill exercise time until the onset of intermittent claudication in older patients with peripheral arterial disease at six months and at one year after treatment. , 2003, The American journal of cardiology.

[92]  L. Norgren,et al.  Inter-society consensus for the management of peripheral arterial disease. , 2007, International angiology : a journal of the International Union of Angiology.

[93]  M. Prins,et al.  Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication. , 2013, The Cochrane database of systematic reviews.

[94]  D. Ewald,et al.  Hospital separations indicate increasing need for prevention of diabetic foot complications in central Australia. , 2001, The Australian journal of rural health.

[95]  John V. White,et al.  Global vascular guidelines on the management of chronic limb-threatening ischemia. , 2019, Journal of vascular surgery.

[96]  R. Peters,et al.  Smoking and the patency of lower extremity bypass grafts: a meta-analysis. , 2005, Journal of vascular surgery.

[97]  S. Munteanu,et al.  Defining the gap: a systematic review of the difference in rates of diabetes-related foot complications in Aboriginal and Torres Strait Islander Australians and non-Indigenous Australians , 2017, Journal of Foot and Ankle Research.

[98]  Paolo Prandoni,et al.  Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[99]  Gerald Gartlehner,et al.  [GRADE guidelines 15: going from evidence to recommendation - determinants of a recommendation's direction and strength]. , 2014, Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen.

[100]  Elizabeth Selvin,et al.  Prevalence of and Risk Factors for Peripheral Arterial Disease in the United States: Results From the National Health and Nutrition Examination Survey, 1999–2000 , 2004, Circulation.

[101]  Janet B. Dunbar,et al.  Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. , 1996, International journal of epidemiology.

[102]  G. Lip,et al.  Ethnic differences in the prevalence of peripheral arterial disease: a systematic review and meta-analysis , 2017, Expert review of cardiovascular therapy.

[103]  B. Keymeulen,et al.  The ankle--brachial index and the diabetic foot: a troublesome marriage. , 2011, Annals of vascular surgery.

[104]  L. Garcia Epidemiology and pathophysiology of lower extremity peripheral arterial disease. , 2006, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[105]  R. Forsythe,et al.  Guidelines on diagnosis, prognosis, and management of peripheral artery disease in patients with foot ulcers and diabetes (IWGDF 2019 update) , 2020 .

[106]  Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial. , 1995, The American journal of cardiology.

[107]  P. Norman,et al.  High rates of amputation among Indigenous people in Western Australia , 2010, The Medical journal of Australia.

[108]  J. Stevens,et al.  Cost-Effectiveness of Cilostazol, Naftidrofuryl Oxalate, and Pentoxifylline for the Treatment of Intermittent Claudication in People With Peripheral Arterial Disease , 2014, Angiology.

[109]  T. Lancaster,et al.  Nicotine receptor partial agonists for smoking cessation. , 2016, The Cochrane database of systematic reviews.

[110]  A. Boulton,et al.  Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. , 2001, Diabetes care.

[111]  R. Langer,et al.  Ethnicity and Peripheral Arterial Disease: The San Diego Population Study , 2005, Circulation.

[112]  M. Young,et al.  Improved Survival of Diabetic Foot Ulcer Patients 1995–2008 , 2008, Diabetes Care.

[113]  J. van de Voorde,et al.  Endothelial dysfunction in diabetes , 2000, British journal of pharmacology.

[114]  R. Forsythe,et al.  Effectiveness of revascularisation of the ulcerated foot in patients with diabetes and peripheral artery disease: A systematic review , 2020, Diabetes/metabolism research and reviews.

[115]  D. Armstrong,et al.  The accuracy and cost-effectiveness of strategies used to identify peripheral artery disease among patients with diabetic foot ulcers. , 2016, Journal of vascular surgery.

[116]  R. Chenhall,et al.  Health beliefs and behavior: the practicalities of "looking after yourself" in an Australian aboriginal community. , 2013, Medical anthropology quarterly.

[117]  G. Guyatt,et al.  [GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines]. , 2018, Gaceta sanitaria.

[118]  K. Eriksson,et al.  Early revascularization after admittance to a diabetic foot center affects the healing probability of ischemic foot ulcer in patients with diabetes. , 2014, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.